PROPHASE LABS, INC. INDUCEMENT OPTION AWARD AGREEMENTInducement Option Award Agreement • May 20th, 2024 • ProPhase Labs, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT (the “Agreement”), is made effective as of the 1st day of January 2024 (hereinafter called the “Date of Grant”), between ProPhase Labs, Inc., a Delaware corporation (hereinafter called the “Company”), and Jed Latkin (hereinafter called the “Optionee”):
PROPHASE LABS, INC. INDUCEMENT OPTION AWARD AGREEMENTInducement Option Award Agreement • December 1st, 2021 • ProPhase Labs, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT (the “Agreement”), is made effective as of the 19th day of November, 2021 (hereinafter called the “Date of Grant”), between ProPhase Labs, Inc., a Delaware corporation (hereinafter called the “Company”), and Samad Beeler (hereinafter called the “Optionee”):
STEIN MART, INC. INDUCEMENT OPTION AWARD AGREEMENT FOR MARYANNE MORINInducement Option Award Agreement • February 24th, 2017 • Stein Mart Inc • Retail-family clothing stores • Florida
THIS INDUCEMENT OPTION AWARD AGREEMENT FOR MARYANNE MORIN (the “Award Agreement”) is made and entered into as of the date first set forth on the signature page hereof (the “Grant Date”) by and between STEIN MART, INC., a Florida corporation (the “Company”), and MaryAnne Morin (the “Key Employee”).
PROPHASE LABS, INC. INDUCEMENT OPTION AWARD AGREEMENTInducement Option Award Agreement • May 9th, 2024 • ProPhase Labs, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT (the “Agreement”), is made effective as of the 1st day of January 2024 (hereinafter called the “Date of Grant”), between ProPhase Labs, Inc., a Delaware corporation (hereinafter called the “Company”), and Jed Latkin (hereinafter called the “Optionee”):
PROPHASE LABS, INC. INDUCEMENT OPTION AWARD AGREEMENTInducement Option Award Agreement • May 10th, 2022 • ProPhase Labs, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT (the “Agreement”), is made effective as of the 9th day of May, 2022 (hereinafter called the “Date of Grant”), between ProPhase Labs, Inc., a Delaware corporation (hereinafter called the “Company”), and Bill White (hereinafter called the “Optionee”):
